



Година | Наслов | Аутор(и) | Тип резултата | Мп-кат. |
---|---|---|---|---|
2025 | Systemic Lupus Erythematosus Disease Activity Avaluation Using Novel Outcome Measures-Lfa-Real Clinician Reported Outcome (Lfa-Real Clinro) and Systemic Lupus Erythematosus Disease Activity Score (Sle-Das): Experience from Our Cohort![]() | Mišković, Rada ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() | Конференцијски рад | Мп категорија ће бити приказана накнадно. |
2025 | A Potential Oncoprotective Role of Cytomegalovirus Against Breast Cancer: Worldwide Correlation and Survey of Evidence![]() | Janković, Marko ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() | Научни чланак | 22M22 - Међународни часопис категорије M22 |
2025 | Seroprevalence of Measles-, Mumps-, and Rubella-Specific Antibodies in Future Healthcare Workers in Serbia: A Cross-Sectional Study![]() | Banko, Ana V. ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() | Научни чланак | 21M21 - Водећи међународни часопис категорије M21 |
2024 | Hepatitis B Surface Antigen Isoforms: Their Clinical Implications, Utilisation in Diagnosis, Prevention and New Antiviral Strategies![]() | Lazarević, Ivana ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() | Article | 22M22 |
2024 | Quantitative HBV Core Antibodies as a Prognostic Marker for HBeAg Seroclearance: A Systematic Review with Meta-Analysis![]() | Lazarević, Ivana B. ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() | Reviews | 21M21 |
2024 | Active/Recent Epstein-Barr Virus Infection in Association with the Onset and Poor Control of Rheumatoid Arthritis![]() | Basarić, Milica M.; Jeremić, Ivica P. ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() | Conference Paper | Mp. category will be shown later |
2024 | Significance of Cytomegalovirus gB Genotypes in Adult Patients Undergoing Hematopoietic Stem Cell Transplantation: Insights from a Single-Centre Investigation![]() | Vasiljević, Tamara; Janković, Marko ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() | Article | 21aM21a |
2024 | Epstein-Barr Virus and Human Papillomavirus Coinfection in Colorectal Carcinoma: Systematic Review and Meta-Analysis of the Prevalence![]() | Banko, Ana V. ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() | Article | 21M21 |
2024 | Association between IL10RA gene haplotypes and rheumatoid arthritis susceptibility![]() | Grk, Milka B. ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() | Conference Paper | Mp. category will be shown later |
2023 | Epstein–Barr Virus Reactivation as a New Predictor of Achieving Remission or Lupus Low Disease Activity State in Patients with Systemic Lupus Erythematosus with Cutaneous Involvement![]() | Mišković, Rada ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() | Article | 21M21 |
2023 | Association of IL10RA</i>, IL10RB</i>, and IL22RA</i> Polymorphisms/Haplotypes with Susceptibility to and Clinical Manifestations of SLE![]() | Grk, Milka ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() | Article | 21M21 |
2023 | Systematic review with meta-analysis of active herpesvirus infections in patients with COVID-19: Old players on the new field![]() | Banko, Ana ![]() ![]() ![]() ![]() ![]() ![]() | Article | 21aM21a |
2023 | Clinical Utility of Quantitative HBV Core Antibodies for Solving Diagnostic Dilemmas![]() | Lazarević, Ivana ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() | Article | 21M21 |
2023 | Epstein-Barr virus positive gastric adenocarcinoma with systemic EBV reactivation in a patient with persistently active systemic lupus erythematosus![]() | Mišković, Rada ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() | Article | 23M23 |
2023 | Analysis of the association between IL10RA gene haplotypes and the occurrence of Sjögren (SLE-SS) syndrome in patients with Systemic Lupus Erythematosus![]() | Grk, Milka ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() | Conference Paper | Mp. category will be shown later |
2023 | Association between IL10RA rs3135932 polymorphism and rheumatoid arthritis susceptibility![]() | Grk, Milka ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() | Conference Paper | Mp. category will be shown later |
2023 | Clinical efficacy of anti‐SARS‐CoV‐2 monoclonal antibodies in preventing hospitalisation and mortality among patients infected with Omicron variants: A systematic review and meta‐analysis![]() | Miljanović, Danijela ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() | Article | 21a+M21a+ |
2023 | Markers of Epstein–Barr Virus Infection in Association with the Onset and Poor Control of Rheumatoid Arthritis: A Prospective Cohort Study![]() | Miljanović, Danijela ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() | Article | 21M21 |
2023 | Epstein-Barr virus infection as potential indicator of the occurrence and clinical presentation of systemic lupus erythematosus![]() | Banko, Ana ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() | Article | 21M21 |
2023 | Uncovering the Role of Epstein–Barr Virus Infection Markers for Remission in Rheumatoid Arthritis![]() | Banko, Ana ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() | Article | 21M21 |